Several earlier publications have noted the involvement of FOXM1 in inflammation in keratinocytes and in other types of cancer [35], and resistance to endocrine therapies in breast cancer has been shown to result in the upregulation of interferon signaling [12]. Here, FOXM1 is linked to breast carcinoma.